Patient transcriptomic based in vivo functional genetic dissection of NAFLD for therapeutic target identification
Chronic liver disease is a leading cause of death globally and non-alcoholic fatty liver disease (NAFLD) is put in the spotlight with increasing prevalence. With no effective therapeutics apart from lifestyle modifications and liver transplantation, treatment of NAFLD remains a challenge. As NAFLD i...
Main Author: | Moo, Jia Rong |
---|---|
Other Authors: | - |
Format: | Final Year Project (FYP) |
Language: | English |
Published: |
Nanyang Technological University
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/166383 |
Similar Items
-
Genome wide in-vivo functional genetic screen to identify novel modulators of Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Lian, Ying
Published: (2022) -
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma
by: Alfredo Smiriglia, et al.
Published: (2023-12-01) -
Molecular and genetic dissection of dilated cardiomyopathy
by: Hafizah Khalidh
Published: (2015) -
Functional dissection of membrane contacts sites in neuronal health in C. elegans
by: Nur Raihanah Binte Mohd Harion
Published: (2023) -
Gut-liver axis in nonalcoholic fatty liver disease (NAFLD)
by: Koo, Yolanda Wei Ling
Published: (2023)